Articles by Roger Dabbah - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Roger Dabbah

A Quality-Control Guide Fails to Train the Trainer

A book about developing quality-control training manuals provides a wealth of information and a dearth of practical help.
Aug 2, 2011

A book about developing quality-control training manuals provides a wealth of information and a dearth of practical help.

An Unfocused Handbook on Environmental Monitoring

An expert-panel-written book has surprising shortcomings.
Oct 20, 2010

An expert-panel-written book has surprising shortcomings.

An Unfocused Handbook on Environmental Monitoring

An expert-panel-written book has surprising shortcomings.
Oct 2, 2010

An expert-panel-written book has surprising shortcomings.

More Than You Need to Know about Manufacturing Pharmaceutical Proteins

The author of a book about biopharmaceutical production includes irrelevant information.
Aug 2, 2009

The author of a book about biopharmaceutical production includes irrelevant information.

No Excuse for Nonconformance

An updated book provides essential information for scientists who monitor microbial quality.
Mar 2, 2009

An updated book provides essential information for scientists who monitor microbial quality.

A Guide That Perplexes

Despite its flaws, a recent release fills a need for books about pharmaceutical project management.
Aug 2, 2008

Despite its flaws, a recent release fills a need for books about pharmaceutical project management.

The Role of USP in the Assessment of Microbiological Quality of Pharmaceuticals

Jul 1, 2001

USP ensures the microbiological quality of products by way of the development, proposal, and acceptance of general information chapters.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here